Multidisciplinary

Top Medical News
an hour ago
Psoriasis patients taking systemic anti-inflammatory agents have a significantly lower risk of Parkinson’s disease, a recent study has shown.
Stephen Padilla, an hour ago
A retrospective study in a single centre in the Philippines has found that cancer patients with recent anticancer treatment, particularly chemotherapy, and who tested positive for the novel coronavirus disease (COVID-19) have higher rates of severe complications. In addition, these patients tend to acquire infection in the hospital, which then leads to an increased risk of severe illness.
Audrey Abella, 3 hours ago
Nucleoside reverse transcriptase inhibitors (NRTIs), a class of drugs approved for treating HIV-1 and hepatitis B, may be repurposed for the prevention of type 2 diabetes (T2D), a study suggests.
Tristan Manalac, 4 hours ago
The risk of clinical progression, invasive mechanical ventilation, and death among patients with the novel coronavirus disease (COVID-19) may be attenuated by a combination treatment of corticosteroids and antivirals, according to a recent Singapore study.
5 hours ago
All intensities of physical activity (PA) seem to improve markers of cardiometabolic health among obese adults, including insulin sensitivity and plasma lipid profile, a recent study has found. In contrast, a high degree of sedentary behaviour (SB) negatively impacts cardiometabolic health.
Roshini Claire Anthony, 19 hours ago

A daily dose of omega-3 carboxylic acid does not appear to reduce the incidence of major adverse cardiovascular events (MACE)*, according to the STRENGTH** trial presented at AHA 2020.

Pearl Toh, 23 hours ago
With more trial data on COVID-19 vaccine pouring in, reports for at least two leading COVID-19 vaccine candidates, the mRNA-1273 vaccine and the adenovirus-vectored ChAdOx1 nCoV-19 vaccine, have indicated that they may also be effective in older individuals — a population known to be at a heightened risk of severe COVID-19 illness.
Special Reports
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
01 Dec 2020
At the recent Pfizer webinar “Pneumococcal Vaccination in High-Risk Individuals: Are We Doing It Right?”, Dr Petrick Periyasamy, head of the Hospital Canselor Tuanku Muhriz UKM Infectious Diseases Unit, discussed the currently known epidemiology of adult pneumococcal disease (PD),as well as the impact of vaccines on PD prevention in at-risk populations.
01 Dec 2020
Dacomitinib 15 mg FC tab
01 Dec 2020
Alpelisib 50 mg, 150 mg and 200 mg FC tab
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
26 Nov 2020
At a Pfizer-sponsored webinar held in collaboration with the Malaysian Medical Association, several distinguished speakers shared their insights into the current SARSCOV-2 pandemic, better known as COVID-19. Topics discussed include current and future therapeutic interventions from both local and global perspectives.
23 Nov 2020
Heart failure (HF) is a global public health concern, affecting about 38 million individuals globally.1 Despite significant medical advances, HF remains a chronic and progressive condition that can negatively affect patients’ quality of life (QoL).2,3 In this case study, Dr Abdul Muizz shares his clinical experience in managing a patient with HF and reduced ejection fraction (HFrEF), following the percutaneous coronary intervention, showing how the initiation of sacubitril/valsartan therapy (an angiotensin receptor/neprilysin inhibitor [ARNI]) changed the clinical outcome of this patient.
Conference Reports
Roshini Claire Anthony, 03 Dec 2020

A daily dose of omega-3 carboxylic acid does not appear to reduce the incidence of major adverse cardiovascular events (MACE)*, according to the STRENGTH** trial presented at AHA 2020.

Roshini Claire Anthony, 02 Dec 2020

People with HIV (PWH) who are hospitalized due to COVID-19 may have an increased mortality risk, according to a study from the UK.

Elvira Manzano, 02 Dec 2020
Giving crushed prasugrel to patients with ST-segment elevation myocardial infarction (STEMI) en route to the hospital for planned PCI* does not improve reperfusion rates compared with giving the tablets whole in the COMPARE CRUSH trial.
Roshini Claire Anthony, 01 Dec 2020

An evidence-based, multifaceted intervention aimed at reducing haemodialysis catheter-related bloodstream infections (HD-CRBSIs) failed to improve this outcome, results of the REDUCCTION* trial showed.

Elvira Manzano, 30 Nov 2020
HIV patients hospitalized for COVID-19 are at a higher risk of mortality than those hospitalized without HIV in a new study reported at HIV Glasgow 2020.
Pearl Toh, 28 Nov 2020
Using regional citrate for anticoagulation during dialysis significantly extends the lifespan of dialysis filter compared with systemic heparin anticoagulation, although this has no impact on the patients’ mortality rate over 1 year, according to the RICH study presented at ASN 2020.
Roshini Claire Anthony, 27 Nov 2020

The efficacy of lanifibranor in reducing histological markers of non-alcoholic steatohepatitis (NASH) is comparable in patients with and without type 2 diabetes (T2D), according to the phase IIb NATIVE study presented as a poster at AASLD 2020.

CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download